Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapy

Published:2012-06-24 Issue:4 Volume:36 Page:312-323
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Bessissow T.,Renard M.¹,Hoffman I.²,Vermeire S.³,Rutgeerts P.³,Assche G.³

Affiliation:

1. Department of Haematology; University Hospital Gasthuisberg; Leuven; Belgium

2. Department of Pediatric Gastroenterology; University Hospital Gasthuisberg; Leuven; Belgium

3. Department of Gastroenterology; University Hospital Gasthuisberg; Leuven; Belgium

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2012.05189.x/fullpdf

Reference94 articles.

1. TNF-mediated inflammatory disease;Bradley;J Pathol,2008

2. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease;Breese;Gastroenterology,1994

3. Practice Parameters Committee of American College of Gastroenterology. Management of Crohn's disease in adults;Lichtenstein;Am J Gastroenterol,2009

4. Differentiating the efficacy of the tumor necrosis factor inhibitors;Haraoui;Semin Arthritis Rheum,2005

5. Austrian Society of Gastroenterology and Hepatology. A decade of infliximab: the Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease;Miehsler;J Crohns Colitis,2010

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Related Adverse Events and Monitoring of Patients Receiving Biologic or Small Molecule Therapy for Inflammatory Bowel Disease;Canadian IBD Today;2024-09-11

2. A patient with axial spondylarthritis who experienced pancytopenia while receiving anti-TNF therapy;Clinical Rheumatology;2024-07-06

3. Risk of neutropenia in psoriasis patients prescribed anti-IL-23 antibody in comparison with anti-IL-17 antibody or adalimumab based on real-world data from the MID-NET ^® in Japan;Journal of Dermatological Treatment;2024-07-04

4. EVALUATION OF DRUG SIDE EFFECT PROFILES IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASE USING TUMOR NECROSIS FACTOR-ALPHA INHIBITORS;Rheumatology Quarterly;2024-05-21

5. Febrile neutropenia associated with adalimumab in a patient with ulcerative colitis;Clinical Case Reports;2024-03-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3